Evrysdi (Risdiplam)

Evrysdi (risdiplam) is an oral daily therapy for patients, ages 2 months and older, with all types of spinal muscular atrophy (SMA). It is a small-molecule treatment that patients take at home as a liquid. The U.S. Food and Drug Administration (FDA) approved it on Aug. 7, 2020, making it the...